title: Expression of pituitary hormones in the Pax8-/- mouse model of congenital hypothyroidism.
abstract: Signaling mechanisms in pituitary morphogenesis as well as pituitary cell fate determination during early embryonic development are relatively well characterized. In contrast, the cues that determine the progression of the various anterior pituitary cell types during postnatal periods are poorly defined. Pax8-/- mice, which are born without a thyroid gland, were used to study the influence of thyroid hormones on the expression of pituitary hormones during early postnatal life. Serum pituitary hormones were determined by RIAs, and the pituitaries were analyzed by Northern blotting, in situ hybridization histochemistry, and immunocytochemistry. In 21-d-old Pax8-/- mice, the cellular composition of the anterior pituitary was dramatically distorted. Thyrotropes exhibited hypertrophy and hyperplasia, the number of detectable somatotropes was drastically reduced, and lactotropes were almost undetectable. Expression of LH and FSH was also reduced, but ACTH and proopiomelanocortin expression was not significantly different. Serum pituitary hormone levels were changed correspondingly. T(4) replacement therapy for variable time periods normalized TSH and GH mRNA expression within 3 d but not prolactin expression, not even when T(4) was administered for 6 d in combination with estradiol. These findings reveal the importance of thyroid hormones in developing the appropriate proportions of anterior pituitary cell types, especially with regard to lactotropes.
authors: Max-Planck-Institut für experimentelle Endokrinologie, D-30625 Hannover, Germany.
authors: Sönke
authors: S
authors: Friedrichsen
authors: Stephanie
authors: S
authors: Christ
authors: Heike
authors: H
authors: Heuer
authors: Martin K H
authors: MK
authors: Schäfer
authors: Albert F
authors: AF
authors: Parlow
authors: Theo J
authors: TJ
authors: Visser
authors: Karl
authors: K
authors: Bauer
mesh_terms: D000367:Age Factors; D000818:Animals; D015152:Blotting, Northern; D003409:Congenital Hypothyroidism; D004268:DNA-Binding Proteins / Q000235:genetics*; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D007037:Hypothyroidism / Q000503:physiopathology*; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D009687:Nuclear Proteins; D000072636:PAX8 Transcription Factor; D051761:Paired Box Transcription Factors; D010903:Pituitary Gland, Anterior / Q000502:physiology*; D010907:Pituitary Hormones / Q000235:genetics*; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis; D013961:Thyroid Gland / Q000002:abnormalities; D013963:Thyroid Hormones / Q000494:pharmacology; D015534:Trans-Activators / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D000072636:PAX8 Transcription Factor; D051761:Paired Box Transcription Factors; C499496:Pax8 protein, mouse; D010907:Pituitary Hormones; D012333:RNA, Messenger; D013963:Thyroid Hormones; D015534:Trans-Activators; D004958:Estradiol